These IT, Pharma Stocks Have Returned More Than 50% So Far This Calendar Year 2020

These Five Stocks Have Returned Over 50% So Far In 2020

Domestic stock markets registered wild swings in calendar year 2020, with the benchmark S&P BSE Sensex index registering its worst loss ever in absolute terms, in March, and bouncing back to touch record highs in December. The coronavirus outbreak, out-performance by technology and pharma shares and a subsequent liquidity-driven rally have been the dominant market themes this year. Investors are still weighing the impact of government measures on tackling the pandemic amid still-rising infections, say analysts. 

During this period, some investors have grown wealthier and wiser with their bets. In the Nifty basket of 50 shares, for example, there are 33 gainers so far this year, led by IT and pharma- or healthcare-related stocks. 

Here are the year’s biggest Nifty winners of 2020 (at current levels):       

Divi’s Laboratories: +95.67%
Dr Reddy’s Laboratories: +74.91%
Cipla: +64.51%
Infosys: +57.29%
HCL Tech: +52.02%
Asian Paints: +41.96%
Wipro: +41.46%
Mahindra & Mahindra: +34.22%
Tata Steel: +33.21%
JSW Steel: +33.12%

And here are 10 laggards on the index: 

NTPC: -12.47%
Axis Bank: -17.89%
SBI: -18.16%
BPCL: -18.27%
ONGC: -22.63%
Indian Oil: -23.82%
UPL: -24.38%
Coal India: -32.81%
IndusInd Bank: -38.51%
Eicher Motors: -89.29%


Source link
#Pharma #Stocks #Returned #Calendar #Year

Leave a Comment